BPC-157 attenuated diclofenac-induced gastrointestinal, liver, and encephalopathy damage in rats — comprehensive multi-organ NSAID toxicity protection from a single peptide agent.
Key findingBPC-157 attenuated diclofenac-induced gastrointestinal, liver, and encephalopathy damage in rats — comprehensive multi-organ NSAID toxicity protection
What the researchers found
BPC-157 attenuated diclofenac-induced gastrointestinal, liver, and encephalopathy damage in rats — comprehensive multi-organ NSAID toxicity protection from a single peptide agent.
Why it matters
Relevant for peptide research.
How the study worked
research study.
What this study cannot tell us
See abstract.
How to read the evidence
emerging evidence.
When this study was published
Published in 2011.
The bigger picture
Advances peptide research.
Questions still open
- Further research needed.
Common questions
What was studied?
What was found?
Read the original research
Pentadecapeptide BPC 157 and its effects on a NSAID toxicity model: diclofenac-induced gastrointestinal, liver, and encephalopathy lesions.
Life sciences, 88(11-12), 535-42
Citation
Ilic, Spomenko; Drmic, Domagoj; Franjic, Sandra; Kolenc, Danijela; Coric, Marijana; Brcic, Luka; Klicek, Robert; Radic, Bozo; Sever, Marko; Djuzel, Viktor; Filipovic, Marinko; Djakovic, Zeljko; Stambolija, Vasilije; Blagaic, Alenka Boban; Zoricic, Ivan; Gjurasin, Miroslav; Stupnisek, Mirjana; Romic, Zeljko; Zarkovic, Kamelija; Dzidic, Senka; Seiwerth, Sven; Sikiric, Predrag. (2011). Pentadecapeptide BPC 157 and its effects on a NSAID toxicity model: diclofenac-induced gastrointestinal, liver, and encephalopathy lesions.. Life sciences, 88(11-12), 535-42. https://doi.org/10.1016/j.lfs.2011.01.015